QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly to Advance Nucleic Acid Therapies for Central and Peripheral Nervous System Diseases Business Wire Multi-program collaboration leveraging QurCan’s TERP™ polymer-lipid nanoparticle delivery platform Lilly to make a strategic investment in QurCan
PSG Equity Holds Final Close of Third European Fund at Over €4.4 Billion Business Wire Fund hits hard cap; commitments significantly exceed size of PSG Europe II Strong support from new and long-term investors signals continued demand for PSG Equity’s investment strategy Focused on scaling up European software and technology companies and building them into pan-European category leaders with global reach
S&P Global Leads Strategic Investment in Kaiko, Extending Series B to $110 Million Business Wire Global financial institutions are funding the leading provider of data services for 24/7 onchain finance, and establishing a Kaiko-chaired industry working group to focus on data infrastructure for tokenized markets.
Xapien Secures $56 Million to Scale Dynamic Due Diligence Globally September 11, 2026 Business relationships now move faster than the processes built to protect them. Xapien's dynamic approach breaks a decades old compromise between speed and assurance. Growing 350%+ in Annual Recurring Revenue over the last 24 months, Xapien is helping clients eliminate unmonitored third-party risk.
Record Currency Management wins new FX Alpha and Frontier Market mandates September 10, 2026 Record Currency Management Ltd (RCM), a subsidiary of London-listed Record plc (Record Financial Group), is pleased to announce that it has been awarded two new mandates of strategic importance – an FX Alpha mandate and an FX Frontier mandate. RCM is the UK currency management arm of Record Financial Group, the London-listed specialist investment group [...]
Alkermes Announces Launch of 9th Annual Alkermes Pathways Research Awards® Program September 10, 2026 — Competitive Grant Program to Offer Individual Grants of Up to $100,000 per Project — — Areas of Interest Expanded to Include Narcolepsy and Idiopathic Hypersomnia in Addition to Schizophrenia and Bipolar I Disorder — — Stage One Submission Period Runs From Sept. 11, 2026 Through Oct. 16, 2026 —
Ride Therapeutics Announces up to US$7.3 Million Investment from the Cystic Fibrosis Foundation to Advance Next-Generation Genetic Medicines September 10, 2026 Investment will support Ride's Molecular Logistics™ platform with the goal of delivering genetic medicines to the lung for all people living with cystic fibrosis Ride’s platform is designed to learn the rules of delivery by tracking the destinations of millions of diverse carriers for genetic medicines in the body Billions of datapoints can be used to train a generative AI design engine and produce optimized carriers for any tissue or cell type of interest Investment is expected to both accelerate Ride’s existing progress using IV delivery and support expansion of the technology for inhaled delivery Ride was launched in 2023, funded by an US$8.0 million seed round
Transition Bio Partners with the Little Warrior Foundation September 10, 2026 Transition Bio receives $750,000 grant from the Little Warrior Foundation Mission: advance science in one of cancer’s most elusive targets - EWS-FLI1 Goal: create a therapeutic for an aggressive pediatric cancer – Ewing Sarcoma Leverage Transition Bio’s molecular drug discovery + protein science-based approach Enabled by Transition Bio’s proprietary physical science tools, data and machine learning
EIG Announces Final Close of Senior Infrastructure Debt Fund VI With $4.0 Billion Raised Across Its Direct Lending Platform September 9, 2026 Platform exceeds original $3 billion fundraising target, reflecting broad institutional demand for infrastructure credit
Blee Raises $27 Million to Introduce AI Content Governance to the Enterprise September 8, 2026 Co-led by Fin Capital and SMBC Fin Atlas Beyond Fund, with participation from Hannah Grey VC and National Bank of Canada, and continued backing from Y Combinator, Penny Jar Capital, Cardumen Capital, and Treasury